16 results
424B3
CELU
Celularity Inc - Ordinary Shares
1 Jun 22
Prospectus supplement
4:06pm
Partner at Venel Holdings from November 2010 to present, and at BBHP Medical LLC from October 2016 to present. Before his tenure at BBHP Medical LLC … Oncology from 2012 to 2014. Prior to his tenure at Novartis, from 2008 to 2010, Mr. Dunn served as Senior Corporate Counsel at Sanofi-Aventis U.S
424B3
lpxed
3 May 22
Prospectus supplement
4:06pm
POS AM
cfxsjk
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
424B3
55sszkw28 tnefhr
12 Aug 21
Prospectus supplement
4:21pm
8-K
EX-3.2
270fads
22 Jul 21
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
4:13pm
425
koo6 rc0wxt49yx8h
15 Jun 21
Business combination disclosure
12:00am
8-K
EX-2.1
776r 506ple
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
425
EX-2.1
cd3tihh h7l93vkc
8 Jan 21
Business combination disclosure
7:02am
- Prev
- 1
- Next